1. Home
  2. MTH vs CYTK Comparison

MTH vs CYTK Comparison

Compare MTH & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • CYTK
  • Stock Information
  • Founded
  • MTH 1985
  • CYTK 1997
  • Country
  • MTH United States
  • CYTK United States
  • Employees
  • MTH N/A
  • CYTK N/A
  • Industry
  • MTH Homebuilding
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTH Consumer Discretionary
  • CYTK Health Care
  • Exchange
  • MTH Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • MTH 5.5B
  • CYTK 5.7B
  • IPO Year
  • MTH 1988
  • CYTK 2004
  • Fundamental
  • Price
  • MTH $80.54
  • CYTK $45.82
  • Analyst Decision
  • MTH Hold
  • CYTK Buy
  • Analyst Count
  • MTH 10
  • CYTK 15
  • Target Price
  • MTH $63.47
  • CYTK $83.64
  • AVG Volume (30 Days)
  • MTH 999.2K
  • CYTK 1.1M
  • Earning Date
  • MTH 01-29-2025
  • CYTK 02-25-2025
  • Dividend Yield
  • MTH 3.26%
  • CYTK N/A
  • EPS Growth
  • MTH 2.15
  • CYTK N/A
  • EPS
  • MTH 11.05
  • CYTK N/A
  • Revenue
  • MTH $6,433,727,000.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • MTH $4.39
  • CYTK N/A
  • Revenue Next Year
  • MTH $8.35
  • CYTK $710.83
  • P/E Ratio
  • MTH $7.29
  • CYTK N/A
  • Revenue Growth
  • MTH N/A
  • CYTK N/A
  • 52 Week Low
  • MTH $73.05
  • CYTK $44.49
  • 52 Week High
  • MTH $106.99
  • CYTK $84.92
  • Technical
  • Relative Strength Index (RSI)
  • MTH 50.31
  • CYTK 39.27
  • Support Level
  • MTH $78.96
  • CYTK $44.49
  • Resistance Level
  • MTH $83.27
  • CYTK $48.45
  • Average True Range (ATR)
  • MTH 2.35
  • CYTK 1.65
  • MACD
  • MTH 1.15
  • CYTK -0.08
  • Stochastic Oscillator
  • MTH 73.26
  • CYTK 23.50

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, which are comprised of ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments; homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes and providing warranty and customer services and the financial services segment offer title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: